Jane Chung
2021
In 2021, Jane Chung earned a total compensation of $4.3M as Chief Commercial Officer at SUTRO BIOPHARMA.
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $199,500 |
| Option Awards | $2,043,200 |
| Salary | $188,021 |
| Stock Awards | $1,377,750 |
| Other | $145,003 |
| Total | $4,253,474 |
Chung received $2M in option awards, accounting for 48% of the total pay in 2021.
Chung also received $300K in bonus, $199.5K in non-equity incentive plan, $188K in salary, $1.4M in stock awards and $145K in other compensation.
Rankings
In 2021, Jane Chung's compensation ranked 3,129th out of 12,415 executives tracked by ExecPay. In other words, Chung earned more than 74.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,129 out of 12,415 | 75th |
Division Manufacturing | 1,260 out of 5,508 | 77th |
Major group Chemicals And Allied Products | 511 out of 2,378 | 79th |
Industry group Drugs | 452 out of 2,099 | 79th |
Industry Biological Products, Except Diagnostic Substances | 124 out of 449 | 72nd |
Source: SEC filing on April 22, 2022.
Chung's colleagues
We found four more compensation records of executives who worked with Jane Chung at SUTRO BIOPHARMA in 2021.